These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 10752639)

  • 1. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus.
    Henderson MC; Miranda CL; Stevens JF; Deinzer ML; Buhler DR
    Xenobiotica; 2000 Mar; 30(3):235-51. PubMed ID: 10752639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol from hops (Humulus lupulus L.).
    Guo J; Nikolic D; Chadwick LR; Pauli GF; van Breemen RB
    Drug Metab Dispos; 2006 Jul; 34(7):1152-9. PubMed ID: 16611861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bioflavonoids on hepatic P450 activities.
    Obermeier MT; White RE; Yang CS
    Xenobiotica; 1995 Jun; 25(6):575-84. PubMed ID: 7483658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines.
    Miranda CL; Stevens JF; Helmrich A; Henderson MC; Rodriguez RJ; Yang YH; Deinzer ML; Barnes DW; Buhler DR
    Food Chem Toxicol; 1999 Apr; 37(4):271-85. PubMed ID: 10418944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
    Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.
    Doostdar H; Burke MD; Mayer RT
    Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes.
    Takahashi N; Harttig U; Williams DE; Bailey GS
    Carcinogenesis; 1996 Jan; 17(1):79-87. PubMed ID: 8565141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
    Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
    Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human cytochrome P450 enzymes by hops (Humulus lupulus) and hop prenylphenols.
    Yuan Y; Qiu X; Nikolić D; Chen SN; Huang K; Li G; Pauli GF; van Breemen RB
    Eur J Pharm Sci; 2014 Mar; 53():55-61. PubMed ID: 24342125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes.
    Nikolic D; Li Y; Chadwick LR; Pauli GF; van Breemen RB
    J Mass Spectrom; 2005 Mar; 40(3):289-99. PubMed ID: 15712367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
    Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
    Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.
    Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
    Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline.
    Murray S; Odupitan AO; Murray BP; Boobis AR; Edwards RJ
    Xenobiotica; 2001 Mar; 31(3):135-51. PubMed ID: 11465391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450.
    Muto S; Fujita K; Yamazaki Y; Kamataki T
    Mutat Res; 2001 Aug; 479(1-2):197-206. PubMed ID: 11470492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hop (Humulus lupulus L.) Extract and 6-Prenylnaringenin Induce P450 1A1 Catalyzed Estrogen 2-Hydroxylation.
    Wang S; Dunlap TL; Howell CE; Mbachu OC; Rue EA; Phansalkar R; Chen SN; Pauli GF; Dietz BM; Bolton JL
    Chem Res Toxicol; 2016 Jul; 29(7):1142-50. PubMed ID: 27269377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Multiple Biological Targets of Hops and Bioactive Compounds.
    Bolton JL; Dunlap TL; Hajirahimkhan A; Mbachu O; Chen SN; Chadwick L; Nikolic D; van Breemen RB; Pauli GF; Dietz BM
    Chem Res Toxicol; 2019 Feb; 32(2):222-233. PubMed ID: 30608650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
    Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of butylated hydroxytoluene chemoprevention of aflatoxicosis--inhibition of aflatoxin B1 metabolism.
    Guarisco JA; Hall JO; Coulombe RA
    Toxicol Appl Pharmacol; 2008 Mar; 227(3):339-46. PubMed ID: 18177683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.